JP2006089475A5 - - Google Patents

Download PDF

Info

Publication number
JP2006089475A5
JP2006089475A5 JP2005247050A JP2005247050A JP2006089475A5 JP 2006089475 A5 JP2006089475 A5 JP 2006089475A5 JP 2005247050 A JP2005247050 A JP 2005247050A JP 2005247050 A JP2005247050 A JP 2005247050A JP 2006089475 A5 JP2006089475 A5 JP 2006089475A5
Authority
JP
Japan
Prior art keywords
composition according
dermatitis
decoy
phospholipid
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005247050A
Other languages
English (en)
Japanese (ja)
Other versions
JP4971609B2 (ja
JP2006089475A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005247050A priority Critical patent/JP4971609B2/ja
Priority claimed from JP2005247050A external-priority patent/JP4971609B2/ja
Publication of JP2006089475A publication Critical patent/JP2006089475A/ja
Publication of JP2006089475A5 publication Critical patent/JP2006089475A5/ja
Application granted granted Critical
Publication of JP4971609B2 publication Critical patent/JP4971609B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005247050A 2004-08-27 2005-08-29 核酸皮膚外用製剤 Expired - Fee Related JP4971609B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005247050A JP4971609B2 (ja) 2004-08-27 2005-08-29 核酸皮膚外用製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004248868 2004-08-27
JP2004248868 2004-08-27
JP2005247050A JP4971609B2 (ja) 2004-08-27 2005-08-29 核酸皮膚外用製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007037517A Division JP4767195B2 (ja) 2004-08-27 2007-02-19 核酸皮膚外用製剤

Publications (3)

Publication Number Publication Date
JP2006089475A JP2006089475A (ja) 2006-04-06
JP2006089475A5 true JP2006089475A5 (https=) 2007-04-05
JP4971609B2 JP4971609B2 (ja) 2012-07-11

Family

ID=36230785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005247050A Expired - Fee Related JP4971609B2 (ja) 2004-08-27 2005-08-29 核酸皮膚外用製剤

Country Status (1)

Country Link
JP (1) JP4971609B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI308492B (https=) 2001-02-20 2009-04-11 Anges Mg Inc
JP4602298B2 (ja) * 2006-08-31 2010-12-22 ホソカワミクロン株式会社 医薬製剤
US8530436B2 (en) 2007-01-29 2013-09-10 Transderm, Inc. Methods and compositions for transdermal delivery of nucleotides
JP2009143897A (ja) * 2007-11-19 2009-07-02 Neochemir Inc ニキビ治療剤
WO2009119836A1 (ja) 2008-03-28 2009-10-01 アンジェスＭｇ株式会社 転写因子デコイを有効成分とする外用剤組成物
KR102506169B1 (ko) 2014-09-05 2023-03-08 피오 파마슈티칼스 코프. Tyr 또는 mmp1을 표적화하는 핵산을 사용한 노화 및 피부 장애의 치료 방법
WO2018195355A1 (en) * 2017-04-19 2018-10-25 Rxi Pharmaceuticals Corporation Topical delivery of nucleic acid compounds
KR102253457B1 (ko) * 2019-04-23 2021-05-18 주식회사 메가코스 유효성분의 피부투과율 증가 및 피부 혈관을 강화시키는 화장료 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129139A (ja) * 1984-11-27 1986-06-17 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPS6216431A (ja) * 1985-07-15 1987-01-24 Nakanishi Michio 医薬組成物
JPS6216418A (ja) * 1985-07-15 1987-01-24 Nakanishi Michio ハロプリドン・アセテ−ト含有医薬組成物
JPH0639380B2 (ja) * 1985-10-11 1994-05-25 有限会社アイクス・ラボラトリ産業 消炎鎮痛剤組成物
JPS62142108A (ja) * 1985-12-16 1987-06-25 Aikusu Lab Sangyo:Kk 育毛剤組成物
JP3313891B2 (ja) * 1994-06-21 2002-08-12 ポーラ化成工業株式会社 経皮吸収促進剤及び皮膚外用剤

Similar Documents

Publication Publication Date Title
Seyhan Trials and tribulations of MicroRNA therapeutics
Ling et al. MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Brognara et al. High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222
WO2007089607A3 (en) Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
JP2021531022A5 (https=)
EP2474617A1 (en) Mir for treating neo-angiogenesis
WO2008147438A3 (en) Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US9163235B2 (en) Inhibitors of the miR-15 family of micro-RNAs
EP3800256A1 (en) Combination to be used in therapeutic use against diseases or conditions associated with melanoma, or in diseases or conditions associated with activated b-raf pathway
Kumar et al. Understanding the effect of locked nucleic acid and 2′-O-methyl modification on the hybridization thermodynamics of a miRNA–mRNA pair in the presence and absence of AfPiwi protein
JP2015502365A5 (https=)
WO2008061537A3 (en) Oligonucleotides for modulating target rna activity
HK1252546A1 (en) Transcriptome-wide design of selective, bioactive small molecules targeting rna
CN107083385A (zh) 产热的miRNA调节剂
WO2013096958A8 (en) Compositions and methods for the delivery of biologically active rnas
WO2008092081A8 (en) Targeted delivery of sirna
WO2012046085A3 (en) Methods of inducing insulin production
WO2010003420A2 (en) Treatment of psoriasis and related diseases by mirna modulation
US20110118337A1 (en) Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer
JP2006089475A5 (https=)
AU2022203361A1 (en) Compositions and methods for modulating RNA
Khorkova et al. Long non-coding RNA-targeting therapeutics: discovery and development update
CA2726187A1 (en) Targeted oligonucleotide compositions for modifying gene expression
Chen et al. Aminoguanidine-assembled functional DNA tetrahedron alleviates acute lung injury by targeting the cGAS-STING signaling pathway
WO2011133584A8 (en) Nucleic acid compounds for inhibiting hras gene expression and uses thereof